Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy.
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2366-2368.e3. doi: 10.1016/j.cgh.2020.05.011. Epub 2020 May 11.
Since February 2020, the COVID-19 pandemic has spread to Italy affecting more than 100,000 people. Several studies have reported a high prevalence of gastrointestinal (GI) symptoms, and investigated their potential association with clinical outcomes. The timing, clinical significance, and possible impact on viral spread of GI symptoms presentation have not been fully elucidated. Elevation of liver function tests and other laboratory values has also been reported; however, their prognostic significance has not been clearly established..
自 2020 年 2 月以来,COVID-19 疫情蔓延至意大利,影响了超过 10 万人。有几项研究报告了胃肠道(GI)症状的高发率,并调查了它们与临床结果的潜在关联。胃肠道症状表现的时间、临床意义和对病毒传播的可能影响尚未完全阐明。肝功能检查和其他实验室值的升高也有报道;然而,其预后意义尚未明确。